| HLA per mismatch | HLA-DR mismatches | ||||||
---|---|---|---|---|---|---|---|---|
Subgroup | No. of recipients (cohorts) | HR (95% CI) | I 2 | P a | No. of recipients (cohorts) | HR (95% CI) | I 2 | P a |
Sample size | Â | Â | Â | 0.835 | Â | Â | Â | 0.011 |
 ≥10,000 | 281,141 (5) | 1.06 (1.05–1.07) | 49.1 |  | 145,351 (2) | 1.07 (1.04–1.10) | 0 |  |
 < 10,000 | 8614 (7) | 1.06 (1.03–1.09) | 17.3 |  | 4652 (5) | 1.27 (1.12–1.43) | 48.4 |  |
Nature of data | Â | Â | Â | 0.133 | Â | Â | Â | 0.076 |
 Univariable-unadjusted | 1440 (4) | 1.14 (1.04–1.26) | 24.8 |  | 2598 (2) | 1.39 (1.05–1.83) | 70.0 |  |
 Multivariable-adjusted | 286,755 (12) | 1.06 (1.05–1.07) | 27.4 |  | 150,003 (7) | 1.08 (1.05–1.11) | 58.3 |  |
Data source | Â | Â | Â | 0.683 | Â | Â | Â | 0.011 |
 Registry/Multi-center | 286,283 (6) | 1.06 (1.05–1.07) | 38.9 |  | 145,351 (2) | 1.07 (1.04–1.10) | 0 |  |
 Single-center | 3472 (6) | 1.07 (1.02–1.12) | 26.6 |  | 4652 (5) | 1.27 (1.12–1.43) | 48.4 |  |
Donor source | Â | Â | Â | 0.027 | Â | Â | Â | 0.616 |
 Cadaveric | 138,516 (5) | 1.07 (1.06–1.07) | 0.00 |  | 41,284 (5) | 1.08 (1.04–1.11) | 66.4 |  |
 Living and Cadaveric | 151,239 (7) | 1.05 (1.05–1.06) | 16.4 |  | 108,719 (2) | 1.09 (1.04–1.15) | 55.4 |  |
 Geographical locations |  |  |  | 0.053 |  |  |  | 0.033 |
 Europe | 138,988 (6) | 1.07 (1.06–1.08) | 0.00 |  | 1952 (4) | 1.32 (1.09–1.60) | 59.7 |  |
 North America | 137,880 (4) | 1.05 (1.04–1.06) | 2.1 |  | 145,351 (2) | 1.07 (1.04–1.10) | 0 |  |
 Asia | 225 (1) | 1.24 (1.00–1.55) | – |  | 2700 (1) | 1.23 (1.05–1.45) | – |  |
 Oceania | 12,662 (1) | 1.07 (1.03–1.12) | – |  | 0 | – | – |  |
Year period | Â | Â | Â | 0.175 | Â | Â | Â | 0.026 |
 Prior to 1995 | 103,915 (6) | 1.06 (1.05–1.07) | 0.00 |  | 148,051 (3) | 1.08 (1.04–1.12) | 26.8 |  |
 Not prior to 1995 | 185,626(5) | 1.06 (1.05–1.08) | 60.1 |  | 4054 (4) | 1.36 (0.98–1.88) | 59.7 |  |
 NR | 214 (1) | 0.83 (0.51–1.34) | – | – | – | – | – | – |